By David Bautz, PhD NASDAQ:CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Acquires 12-LOX Inhibitor VLX-1005 for the Treatment of HIT In December 2025, Cadrenal Therapeutics, Inc.

The increased global incidence of hemophilia, along with its concomitant consequences arising from prolonged hemorrhage after an injury and a heightened vulnerability to internal bleeding in joints or ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Flaviviruses, such as dengue and West Nile, cause diverse clinical symptoms and ...

A new generic oral anticoagulant in orodispersible film formulation has won regulatory support in Europe, potentially broadening access and ease of use for patients requiring anticoagulation across ...

1 Department of Biomedical Sciences, Oklahoma State University Centre for Health Sciences, Tulsa, USA. 2 Department of Medical Microbiology and Parasitology, University of Ilorin Teaching Hospital, ...

Tissue factor (TF), a transmembrane protein overexpressed in tumors such as cervical, head and neck, NSCLC, and pancreatic cancers, initiates the extrinsic coagulation pathway under normal ...

Small vesicles in the saliva of people with severe hemophilia A may explain why these patients rarely have bleeds in their mouth and throat. The vesicles contain a protein complex that’s able to ...

A recent study led by MedUni Vienna provides new insights into the mechanisms of coagulation in persons with hemophilia A, the most common form of hemophilia. The research team was able to show that ...

A recent study provides new insights into the mechanisms of coagulation in persons with haemophilia A, the most common form of haemophilia. The research team was able to show that saliva contains ...